| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Abu Dhabi Investment Authority | - | - | - | Detail |
| Alexandria Venture Investments | - | - | - | Detail |
| ArrowMark Partners | - | - | - | Detail |
| BB Biotech Ventures | - | - | - | Detail |
| EDBI | - | - | - | Detail |
| Fidelity Management and Research Company | - | - | - | Detail |
| Julius Baer Group | - | - | - | Detail |
| Pictet Private Equity Investors S.A. | - | - | - | Detail |
| Sequoia Capital China | - | - | - | Detail |
| Viking Global Investors | - | - | - | Detail |
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Oct 2, 2013 | Grant | $ 24.60M | DARPA | Detail |
| Jan 5, 2015 | Series E | $ 450M | Alexion Pharmaceuticals,AstraZeneca,etc. | Detail |
| Nov 20, 2013 | Series Unknown | $ 110M | Flagship Pioneering | Detail |
| Aug 24, 2016 | Series F | $ 474M | AstraZeneca | Detail |
| Dec 6, 2012 | Series Unknown | $ 40M | Flagship Pioneering | Detail |
| Jan 12, 2016 | Grant | $ 20M | Bill & Melinda Gates Foundation | Detail |
| Jan 14, 2014 | Corporate Round | $ 25M | Alexion Pharmaceuticals | Detail |
| Sep 7, 2016 | Grant | $ 8M | Biomedical Advanced Research and Development Authority (BARDA) | Detail |